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TECHNICAL NOTE
Measurement of extracellular fluid volume in patients on
maintenance hemodialysis
BARRY P. MCGRATH, DAVID J. TILLER, JOHN S. HORVATH and JAMES R. JOHNSON
Renal Unit, Royal Prince Alfred Hospital, Sydney, Australia
As clinical evaluation may fail to detect expansion
of as much as 5 liters of extracellular fluId (ECF)
volume in chronic renal failure [1], there is a need for
a rapid, reliable laboratory method to assess this vol-
ume particularly in dialysis patients whose hyperten-
sion does not appear to be responding to effective
ultrafiltration and dietary sodium restriction [2, 3] or
when bilateral nephrectomy is being considered as a
means of controlling high blood pressure [3]. More-
over, certain patients, in particular anephric patients,
may not develop high blood pressure in the face of
ECF volume expansion, thus implying the need for
caution in accepting normotension as a marker of
normovolemia.
In this study, we have measured the ECF volume
using 35S-sulfate in a group of patients receiving
maintenance hemodialysis and compared measure-
ments of exchangeable sodium (NaE) and sulfate
space (SS).
Nineteen patients receiving maintenance hemo-
dialysis had a total of 32 determinations of ECF vol-
ume by the sulfate space method. Ten of these
patients were studied prior to and following a 14-day
period during which each received < 17 mEq of so-
dium per day. Fourteen of these nineteen patients
had simultaneous measurements of sulfate space and
exchangeable sodium on 22 occasions, over a wide
range of sodium and fluid intake (Fig 1). The method
used is a modification of that of Albert [6}. During
the period of dietary sodium restriction, dialyzer
priming and fluid replacement during periods of
hypotension on dialysis were carried out using 5%
dextrose in water,
Na2 3'S04 (The Radiochemical Centre, Amersham,
England) was diluted with normal saline to a concen-
tration of 10 tCi/ml and prepared in 10-ml sterile
vials. Approximately 25 tCi in a weighed syringe was
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injected into a forearm vein. The injectate syringe was
reweighed. Eight to 10 ml of blood was drawn into
dry heparinized tubes at 20, 30, 40, 50 and 60 mm
after injection and 3-ml plasma samples were pre-
pared by protein precipitation with 1 ml of 50%
trichloroacetic acid. One-milliliter samples of the su-
pernatants were counted in a four-channel liquid scin-
tillation counter (Packard model 3380). A standard
was prepared from the injectate vial by making a 1/
100 dilution in water and taking accurately 0.5 ml of
this solution, adding to 2.5 ml of normal plasma and
then treating as for the plasma samples. Sulfate space
was then calculated from the following formula:
SS = VI X Ct Std X Dii factor X 0.91
ZTE counts
where VI = volume injected, Ct Std = counts of
standard (less background), Dii factor = dilution fac-
tor for standard and ZTE counts = zero-time extrap-
olated counts of 35S. This is the antilog value of the
zero-time intercept of the regression line (method of
least squares) for log (counts) vs. time, for the 30-,
40-, 50- and 60-mm samples.
The 30- to 60-mm counts were used to find the
zero-time extrapolated (ZTE) value, as the dis-
appearance of 35S from plasma was found to be negli-
gible in this period, in the absence of renal excretion.
In Fig. 2, sample counts obtained are expressed as
percentage of 20-mm counts and plotted against time
for three groups of patients.
The behavior of 35S-sulfate in the two groups of
dialysis patients is very similar and suggests that
equilibration has been achieved in the 30- to 50-mm
period (Fig. 2). The continued disappearance in
counts from plasma in normal subjects is due almost
entirely to renal excretion [4, 5]. However, the slight
decline in the plasma counts of 35S-sulfate seen in
anephric patients (Fig. 2) has been reported to be due
to a small but significant amount of "nonrenal excre-
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Fig. 1. Simultaneous measurements of NaE and SS in patients
receiving maintenance hemodialysis (N = 22, r = 0.83, P <0.001).
tion" which occurs even in this early period [5]. To
account for this, zero-time extrapolation of counts
was also performed in the measurement of sulfate
space in patients receiving maintenance hemodialysis.
A weighed amount (approximately 25 itCi) of 24Na,
was given orally as a dose in 10 to 15 ml of 0.3 normal
sodium chloride in a polythese-lined cup. The cup
was then rinsed and the rinses were also swallowed.
To prepare the standard, a further weighed amount
(approximately 25 zCi) was diluted with normal sa-
line in a l00-ml volumetric flask and further diluted
to 1 to 100 with 0.3 normal saline. A 5-mi aiiquot of
the final dilution was used as a standard. A 24-hr
collection of urine was obtained from those passing
urine and a 5-ml plasma sample was obtained at the
end of the 24-hr equilibration period. Plasma and
urine samples, the standard and the cup were all
counted 24 hr after administration of the isotope and
sodium space and NaE were calculated as follows:
Sodium space = amount of dose remaining in
patient-amount of dose in plasma per ml. NaE =
sodium space (liters) X plasma sodium concentration
(mEq/liter). This is then expressed as rnEq/kg of
body wt.
There were 13 male controls, with a mean age of
38.6 yr (range, 18 to 55), and 10 female controls,
mean age 41.4 yr (range, 22 to 62). The ECF volume
Fig. 2. Plasma counts of 35S (mean SEM) expressed as percentage
of 20-mm counts plotted against time for three groups of patients.'
(•) normal control patients (N = 23), (U)patients with chronic renal
failure receiving maintenance hemodialysis with kidneys in situ (N =j 19) and (LI) anephric patients (N = 13).
as measured by sulfate space (mean + SFM) was 0.169
0.005 liters/kg, 6.504 0.16 liters/rn2 for men and
0.171 0.005 liters/kg, 6.344 0.16 liters/rn2 for
women. Values for men and women did not differ
significantly (Table 1).
Thirty-two determinations of sulfate space were
made in 19 dialysis patients. Ten patients were stud-
ied before and after a 14-day period of dietary so-
dium restriction (< 17 mEq/day). The mean change
in sulfate space was —2.27 liters, corresponding to a
mean weight change of —2.45 kg (Table 2).
The results for the 22 simultaneous measurements
of sulfate space and total exchangeable sodium (NaE)
are shown in Fig. 1. The correlation between sulfate
space and NaE was significant at the 0.1% level (r =
0.83) over a wide range, with sulfate space values
ranging from 0.16 to 0.29 liters/kg and NaE values
from 37.2 to 65.8 mEq/kg.
Various indicators and radioactive tracers have
Table 1. Normal controls—male and female—clinical and
laboratory data
Patients Ageyr Wçightag sm . Sulfate space 2hters liters/kg liters/m
Male controls
(N 13)
38.6
+3.4
70.4
+2.3
1.82 11.82
+0.29
0.169 6.504
Mean SEM
Female controls
(N 10)
41.4
+4.3
62.5
+3.5
1.67 10.63
+0.48
0.171 6.344
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Table 2. Effect of < 17 mEq Na diet
.Patient
No.
Age
yr
.
Height
cm
Weight, kg Sulfate space, liters
I II iWt I II SS
a. Men 1
2
3
4
5
6
54
26
30
457
47
150.0
160.0
157.5
167.5
175.3
173.5
40.3
53.5
61.0
53.6
61.4
71.3
37.8
50.3
59.3
49.0
61.0
69.7
—2.5
—3.2
— 1.7
—4.6
—0.4
— 1.6
11.01
11.31
15.75
13.02
11.85
10.77
7.61
10.19
14.06
7.74
10.86
8.64
— 3.40
— 1.12
— 1.69
— 5.28
—0.99
— 2.13
b.Women 7
8
9
10
42
50
38
46
155.5
165.0
160.0
164.5
45.0
58.7
54.3
54.0
42.0
57.2
50.3
52.0
—3.0
— 1.5
—4.0
— 2.0
10.57
11.56
12.16
9.95
9.17
8.64
8.55
9.75
— 1.40
— 2.92
— 3.61
— 0.20
Mean
SEM
43.5 162.9 55.31 52.86 —2.45
0.40
11.79 9.52 —2.27
0.48
been employed to measure the extracellular space in-
cluding inulin [7], thiocynate [8], thiosulfate [9], 24so-
dium [10] and 82bromide [8]. Thiocynate, thiosulfate,
sodium and bromide all penetrate cells to a signifi-
cant but variable extent and thereby introduce errors
in the measurement of the ECF volume. 24Sodium has
a short half-life (14.7 hr) and requires a long equili-
bration time, making its general use impractical in
most clinical situations.
35S-sulfate is a convenient isotope to use and
reaches an equilibrium between vascular and inter-
stitial spaces within 15 to 20 mm of i.v. injection in
normal man [4, 5]. Following the initial rapid rate of
disappearance from plasma, there is a second slower
rate which persists for eight to nine hours [5].
Urinary excretion is the major method of elimination
of this isotope, occurring at an exponential rate [4],
and in the normal individual, 50% of the injected dose
is lost from the body in four to eight hours. However,
injected 35S-sulfate leaves the plasma at a faster rate
than it appears in the urine and the exact distribution
of the extrarenal loss is unknown. The exponential
rate of disappearance of 35S-sulfate from the plasma
of patients with significant renal function is thus the
summation of loss by urinary excretion and another
exponential rate of disappearance elsewhere. "Zero-
time" extrapolation of log (counts) is a useful pro-
cedure to account for urinary excretion and minimize
the error arising as a result of nonrenal excretion.
Using this procedure, the values obtained for SS in
our control group of patients are in agreement with
those previously reported [5].
In patients receiving maintenance hemodialysis, we
have found the measurement of SS using 35S-sulfate,
to be a rapid, convenient and reproducible method of
measuring ECF volume. In view of the close relation-
ship between NaE and SS over a wide range of values,
the measurement of SS would seem to be of benefit in
the assessment of states of hydration and in-
vestigation and assessment of hypertension in
patients who are maintained on intermittent hemo-
dialysis.
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